To expand the screening for agents capable of reducing TMZ resistance in glioblastoma, we examined the effects of eight compounds (with IC50 values below 30 μM in LN‐229 cells) on MGMT expression in MGMT‐overexpressing HEK293FT cells. The gene discussed is MGMT; the disease is glioblastoma.